Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Roseth Aass

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Heliyon|March 3, 2025
The viral landscape in metastatic solid cancersRobin Mjelle, Ícaro Castro, Kristin Roseth Aass
Journal of Leukocyte Biology|September 2, 2020
Molecular interactions and functions of IL-32Kristin Roseth Aass, Martin H Kastnes, Therese Standal
Iscience|May 19, 2020
sMETASeq: Combined Profiling of Microbiota and Host Small RNAsRobin Mjelle, Kristin Roseth Aass, Wenche Sjursen, et al.
Frontiers in Oncology|June 14, 2023
The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymesMartin Kastnes, Kristin Roseth Aass, Siri Anshushaug Bouma, et al.
Frontiers in Immunology|March 6, 2023
IL-32 is induced by activation of toll-like receptors in multiple myeloma cellsKristin Roseth Aass, Synne Stokke Tryggestad, Robin Mjelle, et al.
Frontiers in Immunology|June 24, 2024
Toll-like receptor signaling in multiple myeloma cells promotes the expression of pro-survival genes B-cell lymphoma 2 and MYC and modulates the expression of B-cell maturation antigenSynne Stokke Tryggestad, Ingrid Aass Roseth, Kristin Roseth Aass, et al.
Scientific Reports|July 15, 2022
Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myelomaKristin Roseth Aass, Tonje Marie Vikene Nedal, Synne Stokke Tryggestad, et al.
British Journal of Cancer|November 29, 2022
Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survivalKristin Roseth Aass, Tonje Marie Vikene Nedal, Siri Anshushaug Bouma, et al.
Scientific Reports|February 13, 2024
Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myelomaTonje Marie Vikene Nedal, Siv Helen Moen, Ingrid Aass Roseth, et al.
Blood Advances|January 4, 2018
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone lossMuhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Heliyon|March 3, 2025
The viral landscape in metastatic solid cancersRobin Mjelle, Ícaro Castro, Kristin Roseth Aass
Journal of Leukocyte Biology|September 2, 2020
Molecular interactions and functions of IL-32Kristin Roseth Aass, Martin H Kastnes, Therese Standal
Iscience|May 19, 2020
sMETASeq: Combined Profiling of Microbiota and Host Small RNAsRobin Mjelle, Kristin Roseth Aass, Wenche Sjursen, et al.
Frontiers in Oncology|June 14, 2023
The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymesMartin Kastnes, Kristin Roseth Aass, Siri Anshushaug Bouma, et al.
Frontiers in Immunology|March 6, 2023
IL-32 is induced by activation of toll-like receptors in multiple myeloma cellsKristin Roseth Aass, Synne Stokke Tryggestad, Robin Mjelle, et al.
Frontiers in Immunology|June 24, 2024
Toll-like receptor signaling in multiple myeloma cells promotes the expression of pro-survival genes B-cell lymphoma 2 and MYC and modulates the expression of B-cell maturation antigenSynne Stokke Tryggestad, Ingrid Aass Roseth, Kristin Roseth Aass, et al.
Scientific Reports|July 15, 2022
Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myelomaKristin Roseth Aass, Tonje Marie Vikene Nedal, Synne Stokke Tryggestad, et al.
British Journal of Cancer|November 29, 2022
Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survivalKristin Roseth Aass, Tonje Marie Vikene Nedal, Siri Anshushaug Bouma, et al.
Scientific Reports|February 13, 2024
Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myelomaTonje Marie Vikene Nedal, Siv Helen Moen, Ingrid Aass Roseth, et al.
Blood Advances|January 4, 2018
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone lossMuhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, et al.
Pageof 2